Canada Approves Prescription Heroin: Here's What That Means
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Doctors in Canada can now prescribe heroin to patients with particularly serious addictions to the drug, thanks to new rules that were recently approved by the country's government.
The rules, which went into effect last week, allow any doctor in Canada to apply to the country's national health department (known as Health Canada) for access to medical-grade heroin to prescribe to specific patients. The requests are approved on a case-by-case basis, by the government-run Special Access Programme, according to the new regulations.
However, the drug, known medically as diacetylmorphine, can be prescribed only to patients with severe heroin addictions who have tried to end their addiction multiple times with other methods but have failed, the government said.
"Having access to diacetylmorphine will provide health practitioners with an additional treatment option to treat patients with opioid dependence who have not responded to traditional treatments," the new regulations said. (Heroin belongs to the class of pain-relieving drugs known as opioids.) "Treatment with diacetylmorphine in a comprehensive setting can lead to improved treatment outcomes and health benefits for these patients." [10 Interesting Facts About Heroin]
The changes come at a time when opioid overdose deaths in Canada are on the rise. Not all provinces keep track of opioid deaths, but in British Columbia, there were 433 drug overdose deaths between January and July this year, a 75 percent increase over the number of deaths that occurred during that same period in 2015, according to a report from British Columbia Coroners Service. About 62 percent of all drug overdose deaths involved the opioid fentanyl, up from 30 percent of deaths in 2015.
A number of studies have shown that treatment with diacetylmorphine can help addicted patients who've previously failed other treatments. For example, a 2009 study in Canada found that patients with severe heroin addictions were more likely to stick with their addiction treatment and less likely to use illegal drugs if they received diacetylmorphine, compared to standard treatment with the drug methadone.
Prescriptions for diacetylmorphine are also available in some European countries, including Switzerland, Germany, the Netherlands and Denmark, to treat people with opioid dependence who have failed other therapies, the new regulations said.
Get the world’s most fascinating discoveries delivered straight to your inbox.
Patients who get prescriptions for heroin will be supervised by medical staff when they are injecting the drug, according to CNN.
Original article on Live Science.

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.
